| Trial ID: | L0996 |
| Source ID: | NCT00097747
|
| Associated Drug: |
Placebo
|
| Title: |
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia|Chronic Kidney Disease|Chronic Renal Failure|Cancer
|
| Interventions: |
DRUG: Placebo|DRUG: peginesatide
|
| Outcome Measures: |
Primary: Adverse events, 28 Days | Secondary: PK parameters, 28 Days|Pharmacodynamic (PD) parameters, 28 Days
|
| Sponsor/Collaborators: |
Sponsor: Affymax
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2004-08
|
| Completion Date: |
2005-01
|
| Results First Posted: |
|
| Last Update Posted: |
2012-12-21
|
| Locations: |
Research Facility, London, HA1 3UJ, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00097747
|
